Free Trial

Humacyte (HUMA) Insider Trading & Ownership

Humacyte logo
$4.41 -0.01 (-0.23%)
(As of 11/20/2024 ET)

Humacyte (NASDAQ:HUMA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.20%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$369,107.20
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$25.94 M
Get HUMA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Humacyte stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HUMA Insider Buying and Selling by Quarter

Humacyte Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/20/2024Laura E NiklasonCEOSell261,369$4.40$1,150,023.60  
11/19/2024Brady W DouganDirectorSell427,459$4.34$1,855,172.06  
11/18/2024Laura E NiklasonCEOSell811,172$4.44$3,601,603.68  
9/10/2024Kathleen SebeliusDirectorSell5,182$5.40$27,982.80  
9/9/2024Laura E NiklasonCEOSell157,704$5.42$854,755.68  
8/29/2024Brady W DouganDirectorSell352,112$6.35$2,235,911.20  
8/28/2024Laura E NiklasonCEOSell277,090$6.47$1,792,772.30  
8/27/2024Brady W DouganDirectorSell252,676$6.71$1,695,455.96  
8/27/2024Dale A SanderCFOSell39,389$6.68$263,118.52  
6/12/2024Brady W DouganDirectorSell271,518$7.30$1,982,081.40  
6/11/2024Laura E NiklasonCEOSell358,630$7.08$2,539,100.40  
6/4/2024Brady W DouganDirectorBuy2,362$6.35$14,998.70  
6/3/2024Laura E NiklasonCEOBuy2,050$7.37$15,108.50  
5/31/2024Laura E NiklasonCEOSell809,786$7.91$6,405,407.26  
5/30/2024Heather Ledbetter PrichardCOOSell188,886$8.14$1,537,532.04  
5/15/2024Gordon M BinderDirectorBuy50,000$6.78$339,000.00  
(Data available from 1/1/2013 forward)

HUMA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Humacyte includes Brady W Dougan, Dale A Sander, Gordon M Binder, Heather Ledbetter Prichard, Kathleen Sebelius, Laura E Niklason, Michael T Constantino, and William John Scheessele. Learn more on insiders at HUMA.

11.20% of Humacyte stock is owned by insiders. Learn more on HUMA's insider holdings.

The following insiders have purchased HUMA shares in the last 24 months: Brady W Dougan ($14,998.70), Dale A Sander ($52,000.00), Gordon M Binder ($339,000.00), Laura E Niklason ($15,108.50), and William John Scheessele ($15,450.00).

Insiders have purchased a total of 79,412 HUMA shares in the last 24 months for a total of $436,557.20 bought.

The following insiders have sold HUMA shares in the last 24 months: Brady W Dougan ($11,375,565.83), Dale A Sander ($263,118.52), Heather Ledbetter Prichard ($1,574,349.83), Kathleen Sebelius ($27,982.80), and Laura E Niklason ($48,680,845.39).

Insiders have sold a total of 16,961,450 Humacyte shares in the last 24 months for a total of $61,921,862.37 sold.

Tommy Tuberville (R-AL) has bought shares of Humacyte in the last year totaling $73,000. Tommy Tuberville (R-AL) has sold shares totaling $123,500.

Humacyte Key Executives

  • Dr. Laura E. Niklason M.D. (Age 61)
    Ph.D., Founder, President, CEO & Director
    Compensation: $899.25k
  • Mr. Dale A. Sander (Age 64)
    CFO, Chief Corporate Development Officer & Treasurer
    Compensation: $704.33k
    1 recent trades
  • Dr. Heather Ledbetter Prichard Ph.D. (Age 46)
    Chief Operating Officer
    Compensation: $647.78k
    1 recent trades
  • Dr. Juliana L. Blum Ph.D.
    Co-Founder & Executive Advisor
  • Ms. Sabrina Osborne
    Executive Vice President of Business Strategy & People
  • Mr. William John Scheessele (Age 52)
    Chief Commercial Officer
  • Dr. Shamik J. Parikh M.D. (Age 51)
    Chief Medical Officer
    Compensation: $514.72k
  • Mr. Harold Alterson
    Senior Vice President of Quality
  • Dr. Yang Cao M.D. (Age 58)
    Ph.D., Chief Regulatory Officer


This page (NASDAQ:HUMA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners